Loading clinical trials...
Loading clinical trials...
A Combined Neurofeedback- TMS Intervention for Alcohol Use Disorder - Aim 2
The purpose of this study is to help understand how attention processes influence brain engagement during emotion and social cognition. The investigators also want to know if these processes are associated with drinking alcohol. Participation includes three study visits of about 2 hours each over approximately a month. The first visit involves a magnetic resonance imaging (MRI) scan and answering survey questions. Each of the next two visits will involve a session of transcranial magnetic stimulation (TMS, a non-invasive brain stimulation technique) followed by another MRI scan. People in the Auburn/Opelika area 19 or older are eligible to participate. People who drink alcohol and people who do not drink or don't drink very much are invited to participate.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Auburn University
Auburn, Alabama, United States
Start Date
August 11, 2022
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2025
Last Updated
October 7, 2025
40
ESTIMATED participants
TMS
DEVICE
Lead Sponsor
Auburn University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions